These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10728677)

  • 1. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
    Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
    Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.
    Choy KW; Pang CP; Yu CB; Wong HL; Ng JS; Fan DS; Lo KW; Chai JT; Wang J; Fu W; Lam DS
    Hum Mutat; 2002 Nov; 20(5):408. PubMed ID: 12402348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
    Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion.
    Simpson DJ; Clayton RN; Farrell WE
    Oncogene; 2002 Feb; 21(8):1217-24. PubMed ID: 11850841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
    Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
    Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
    Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
    Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
    Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
    Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
    Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
    Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation status of the retinoblastoma gene (RB1) in osteosarcoma: no evidence for hypermethylation.
    Otte C; Scholz R; Werner M; Weber B; Delling G; Kabisch H
    Pediatr Hematol Oncol; 2004; 21(1):57-65. PubMed ID: 14660307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
    Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
    Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
    Simpson DJ; Bicknell JE; McNicol AM; Clayton RN; Farrell WE
    Genes Chromosomes Cancer; 1999 Apr; 24(4):328-36. PubMed ID: 10092131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
    Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
    Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
    Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of pituitary tumors.
    Farrell WE; Clayton RN
    Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [RB1 and CDKN2A functional defects resulting in retinoblastoma].
    Babenko OV; Zemliakova VV; Saakian SV; Brovkina AF; Strel'nikov VV; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2002; 36(5):777-83. PubMed ID: 12391839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
    Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ
    Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.
    Ohtani-Fujita N; Fujita T; Aoike A; Osifchin NE; Robbins PD; Sakai T
    Oncogene; 1993 Apr; 8(4):1063-7. PubMed ID: 8455933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
    Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
    Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.